There’s been another merger in healthcare Big Data.
Wednesday, payer-facing SCIO Health Analytics, of West Hartford, Connecticut, said that it has acquired Westlake Village, California-based Clear Vision Information Systems, for an undisclosed sum.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Clear Vision offers software-as-a-service analytics technology for risk adjustment and quality measurement. The 10-year-old company serves government and commercial health plans, care providers and Accountable Care Organizations.
“By combining Clear Vision’s robust risk adjustment and quality metric analytics, as well as its outreach services, with SCIO’s predictive and prescriptive analytics solutions and services focused on reimbursement and care optimization, we can help our clients manage this transition [to value-based care] more effectively while maximizing care quality, network performance and revenue,” SCIO Health Analytics CEO Siva Namasivayam said.
“The two sets of technologies dovetail nicely to deliver a well-rounded picture of the changes organizations need to make to achieve their goals,” added Clear Vision Founder, President and CEO Tom Peterson. Peterson and Clear Vision Co-founder Pam Klugman have been offered executive positions with SCIO, the companies said.
Photo: Bigstock
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
